en ru

B·R·A·H·M·S biomarkers provide an outstanding long-term lot-to-lot stability and highest precision Ref-1 for most reliable results in prenatal screening. With our biomarker portfolio we are providing solutions from first trimester trisomy and pre-eclampsia as well as second trimester trisomy and neural tube defect screening to an improved diagnosis and prognosis of pre-eclampsia from 20 weeks until term.

pns visual sun products assays

Our prenatal screening products portfolio

References Prenatal Screening Products and Assays

Ref-1: Monthly UK NEQAS reports, February 2003 - November 2021.